Building on manufacturing commitment, BioNTech meets with African leaders
On the heels of its announcement to amp up mRNA Covid-19 vaccine manufacturing in Africa, BioNTech announced it is considering putting vaccine manufacturing sites in Rwanda and Senegal to help beef up the continent’s supply.
BioNTech CEO Ugur Sahin met with Rwandan President Paul Kagame, European Commission President Ursula von der Leyen and Senegalese President Macky Sall to talk about sustainable vaccine manufacturing for Africa, and discuss its already-announced plans to spin its mRNA vaccination production into malaria and tuberculosis vaccine when the need for Covid-19 vaccines becomes less severe.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,700+ biopharma pros reading Endpoints daily — and it's free.